Breast Cancer in 2025: Advancements, Challenges, and Hope Breast cancer remains one of the most common and widely recognized forms of cancer globally, particularly among women. Despite major progress in…
The FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved to be used to prevent a relapse in patients with…
Targeted therapy is a type of cancer treatment that works differently to chemotherapy. Chemotherapy attacks all rapidly dividing cells in the body, but targeted therapy works by “targeting” those differences…
Treatments are less invasive when breast cancer is detected at an early stage. Challenges for breast cancer treatment in Nepal include patient’s financial status (given the huge out-of-pocket expenditure), accessibility…